Announcement on Convening the Q3 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Cisen Pharmaceutical Ltd. on 6ix
Earlier from Cisen Pharmaceutical
- Announcement on Changing Name, Registered Address and Business Scope of Person Acting in Concert of Shareholders with More than 5% of the Shares
- Announcement on By-election of Members of the Remuneration and Evaluation Committee of the 5th Board of Directors
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Completion of Shareholding Reduction Plan for Shareholders with Over 5% Shares and Results of Shareholding Reduction
- Announcement on Resignation of Director and Election of Employee Representative Director
Later from Cisen Pharmaceutical
- Indicative Announcement on Change in Equity of Shareholder with Over 5% Shares and Person Acting in Concert Reaching 1% Scale
- Announcement on Outline of the Q3 2025 Performance Briefing
- Announcement on Using Idle Self-owned Funds for Entrusted Wealth Management and Securities Investment by the Company and its Holding Subsidiary
- Announcement on Release of Pledge of Shareholder's Shares
- Announcement on Changing Sponsor Representative
Follow Cisen Pharmaceutical into a list and get an email when it puts out news.
Follow Cisen Pharmaceutical